© 1995 British Society for Rheumatology
research-article |
INFLAMMATORY CYTOKINE RESPONSES IN JUVENILE CHRONIC ARTHRITIS
*Paediatric Rheumatology Unit, Northwick Park Hospital Harrow
Department of Molecular Medicine, Royal Hallamshire Hospital Sheffield
Correspondence to:
Correspondence to: P. Woo, UCLMS, The Windeyer Bldg, 46 Cleveland Street, London W1P 6DB.
The inflammatory cytokines interleukin 1ß (IL-1ß) interleukin 6 (IL-6), tumour necrosis factor alpha (TNF
) and the anti-inflammatory peptide—the interleukin 1 (IL-1) receptor antagonist—were measured in the plasma of children with juvenile chronic arthritis (JCA). In the two subgroups studied (polyarticular JCA and systemic JCA), there was good correlation between laboratory measures of disease activity C-reactive protein (CRP), erythrocyte sedimentation rate and clinical scores for disease activity. Despite higher levels of CRP in the systemic group IL-1ß levels were lower and regression analysis recorded a difference in the relationship between CRP and IL-1ß within thetwo clinical groups. In contrast, IL-6 levels were high in the systemic group and correlated with disease activity. No such correlation was observed in the polyarticular group. Five children with systemic JCA were studied during the febrile phase of their illness. IL-6 levels rose and fell with the fever. TNF levels also rose and fell but out of phase with the fever. In contrast IL-1ß levels were either undetectable throughout the febrile episode or only became detectable as the temperature reduced to normal. The IL-1 receptor antagonist was usually found in 1000-fold excess over IL-lß, levels rising and falling with the fever. These results demonstrate difference in the cytokine profiles and acute phase protein responses in polyarticular and systemic JCA. This would suggest different pathogenic mechanisms for these two groups of JCA with IL-6 being the more important cytokine in systemic JCA.
KEY WORDS: Cytokines, Juvenile chronic arthritis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. V. Ramanan and A. A. Grom Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology, November 1, 2005; 44(11): 1350 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oen, P. N. Malleson, D. A. Cabral, A. M. Rosenberg, R. E. Petty, P. Nickerson, and M. Reed Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis Rheumatology, September 1, 2005; 44(9): 1115 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Y Chen, J L Lan, F J Lin, T Y Hsieh, and M C Wen Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease Ann Rheum Dis, October 1, 2004; 63(10): 1300 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Wilkinson, G Jackson, and J Gardner-Medwin Biologic therapies for juvenile arthritis Arch. Dis. Child., March 1, 2003; 88(3): 186 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bechtold, P. Ripperger, D. Muhlbayer, H. Truckenbrodt, R. Hafner, O. Butenandt, and H. P. Schwarz GH Therapy in Juvenile Chronic Arthritis: Results of a Two-Year Controlled Study on Growth and Bone J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5737 - 5744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. De Benedetti, C. Meazza, M. Oliveri, P. Pignatti, M. Vivarelli, T. Alonzi, E. Fattori, S. Garrone, A. Barreca, and A. Martini Effect of IL-6 on IGF Binding Protein-3: A Study in IL-6 Transgenic Mice and in Patients with Systemic Juvenile Idiopathic Arthritis Endocrinology, November 1, 2001; 142(11): 4818 - 4826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rooney, H. Varsani, K. Martin, P. R. Lombard, J.-M. Dayer, and P. Woo Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis Rheumatology, April 1, 2000; 39(4): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J G Swaak, H G van den Brink, and L A Aarden Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis Ann Rheum Dis, November 1, 1997; 56(11): 693 - 695. [Abstract] [Full Text]
|
|